Recruiting OBSERVATIONAL NCT06593951
Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1) (EPM1)
Sponsor: Boston Children's Hospital
Conditions
CSTB-related Disease EPM1 Myoclonus Epilepsies, Progressive PME Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature Progressive Myoclonus Epilepsy Type 1 Progressive Myoclonus-Epilepsies Unverricht-Lundborg Disease
Updated 2 times since 2024 Last updated: Oct 10, 2024 Started: Oct 10, 2024 Primary completion: Oct 1, 2029 Completion: Oct 1, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06593951, this observational or N/A phase trial focuses on CSTB-related Disease and EPM1 and remains actively recruiting participants. Sponsored by Boston Children's Hospital, it has been updated 2 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Nov 2024 — Present [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Oct 2024 — Nov 2024 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Boston Children's Hospital
- Epilepsy Foundation
Data source: Boston Children's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .